Sustained Blood Pressure Control Following Discontinuation of a Pharmacist Intervention

Team‐based care can improve hypertension control. The purpose of the present study was to evaluate blood pressure (BP) control 18 months following the discontinuation of a physician‐pharmacist collaborative intervention. This was a retrospective analysis of patients who had previously participated i...

Full description

Saved in:
Bibliographic Details
Published in:The journal of clinical hypertension (Greenwich, Conn.) Conn.), 2011-06, Vol.13 (6), p.431-437
Main Authors: Wentzlaff, Danielle M., Carter, Barry L., Ardery, Gail, Franciscus, Carrie L., Doucette, William R., Chrischilles, Elizabeth A., Rosenkrans, Kurt A., Buys, Lucinda M.
Format: Article
Language:English
Subjects:
Antihypertensive Agents - therapeutic use
Blood Pressure
Cooperative Behavior
Female
Guideline Adherence
Health Knowledge, Attitudes, Practice
Humans
Hypertension - drug therapy
Hypertension - prevention & control
Male
Medication Adherence
Middle Aged
Multivariate Analysis
Original Paper
Original Papers
Patient Care Team
Patient Education as Topic
Pharmacists
Practice Patterns, Physicians
Program Development
Program Evaluation
Retrospective Studies
Statistics as Topic
Time Factors
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Team‐based care can improve hypertension control. The purpose of the present study was to evaluate blood pressure (BP) control 18 months following the discontinuation of a physician‐pharmacist collaborative intervention. This was a retrospective analysis of patients who had previously participated in a prospective, cluster randomized, controlled clinical trial. Six community‐based family medicine offices were randomized to control or intervention groups. Research nurses measured BPs using an automated device during the prospective trial. The research nurses then ed data from medical records, including BPs, medications, changes in therapy, and laboratory values for 18 months following the discontinuation of the 6‐month prospective trial. The study included 228 patients in the control (n=146) or intervention (n=82) groups. The control group contained more patients with diabetes or chronic kidney disease (P
ISSN:1524-6175
1751-7176
DOI:10.1111/j.1751-7176.2011.00435.x